You are here

Takeda

Takeda suffers another setback in its quest to expand myeloma drug’s reach — and blockbuster potential

Takeda suffers another setback in its quest to expand myeloma drug’s reach — and blockbuster potential

Endpoints

clinical trials

Flag link:

FDA approves GATTEX for children with short bowel syndrome

FDA approves GATTEX for children with short bowel syndrome

Pharmaceutical Business Review

short bowel syndrome

Flag link:

May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven

May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven

BioCentury

cervical cancer

non-small cell lung cancer

HER2-positive metastatic breast cancer

Flag link:

Takeda veterans, Frazier launch Phathom with $90M to develop GI drug vonoprazan

Takeda veterans, Frazier launch Phathom with $90M to develop GI drug vonoprazan

BioCentury

Frazier Healthcare

gastrointestinal

Flag link:

J&J's Ethicon Spends $400M for Takeda’s Fibrin Sealant Patch

J&J's Ethicon Spends $400M for Takeda’s Fibrin Sealant Patch

Medical Devices and Diagnostics Industry

Fibrin Sealant Patch

Flag link:

Takeda sells Shire’s Xiidra, transfers 400 staffers to Novartis in $3.4B deal

Takeda sells Shire’s Xiidra, transfers 400 staffers to Novartis in $3.4B deal

Fierce Pharma

dry eye disease

Flag link:

Novartis Considers Offer for Takeda Eye-Disease Assets

Novartis Considers Offer for Takeda Eye-Disease Assets

Bloomberg

Flag link:

Takeda’s Entyvio Ad Captures Struggle to Make Plans

Takeda’s Entyvio Ad Captures Struggle to Make Plans

Xtalks

inflammatory bowel disease

Flag link:

Takeda Unites San Diego Operations At New ‘Biotech-Style’ R&D Center

Takeda Unites San Diego Operations At New ‘Biotech-Style’ R&D Center

Xconomy

Flag link:

Big Pharma come together for better drug side effect detection

Big Pharma come together for better drug side effect detection

Pharma Times

Bristol-Myers Squibb

Gilead Sciences

International Working Group on Signal Detection and Management in Pharmacovigilance

pharmacovigilance

Flag link:

Takeda takes a cautious step into neurological gene therapy, inking preclinical deal with StrideBio

Takeda takes a cautious step into neurological gene therapy, inking preclinical deal with StrideBio

Endpoints

Flag link:

Takeda’s Entyvio Bests Humira in Head-to-Head UC Study

Takeda’s Entyvio Bests Humira in Head-to-Head UC Study

BioSpace

ulcerative colitis

Flag link:

Takeda, Microsoft rare disease partnership publishes diagnosis roadmap

Takeda, Microsoft rare disease partnership publishes diagnosis roadmap

Fierce Pharma

Flag link:

FDA Warns of Increased Risk of Death With Gout Medicine Uloric

FDA Warns of Increased Risk of Death With Gout Medicine Uloric

RAPS.org

Flag link:

NICE backs Takeda’s Alunbrig in second-line lung cancer

NICE backs Takeda’s Alunbrig in second-line lung cancer

Pharmaforum

ALK-positive non-small cell lung cancer

Flag link:

Hurricanes, droughts, and wildfires: How biopharma is girding for climate change

Hurricanes, droughts, and wildfires: How biopharma is girding for climate change

Stat

natural disasters

tropical diseases

Flag link:

Artificial Intelligence Gaining Ground in Drug Development

Artificial Intelligence Gaining Ground in Drug Development

BioSpace

machine learning

artificial intelligence

drug development

Google DeepMind

Recursion Pharmaceuticals

Flag link:

Takeda's Hemophilia A Drug: New Data and a $155 Million Patent Infringement Settlement

Takeda's Hemophilia A Drug: New Data and a $155 Million Patent Infringement Settlement

BioSpace

clinical trials

Flag link:

Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing

Q4 Biopharma Themes: Strong 2018, Weaker 2019 Earnings Projections, Concerns over Drug Pricing

BioSpace

Flag link:

Pages